gsk1016790a gsk1016790a gsk1016790a (aka gsk101) is a drug developed by glaxosmithkline which acts as a potent and selective agonist for the trpv4 receptor. it has been used to study the role of trpv4 receptors in the function of smooth muscle tissue, particularly that lining blood vessels, lymphatic system, and the bladder. gsk1016790aidentifiers iupac name n-amino]-3-hydroxy-1-oxopropyl]-1-piperazinyl]carbonyl]-3-methylbutyl]benzothiophene-2-carboxamide cas number942206-85-1pubchem cid23630211chemspider29310491chebichebi:140524comptox dashboard (epa)dtxsid30635248 chemical and physical dataformulac28h32cl2n4o6s2molar mass655.61 g·mol−13d model (jsmol)interactive image smiles cc(c)c(nc(c1=cc2=cc=cc=c2s1)=o)c(n3ccn(cc3)c((co)ns(=o)(c4=c(cl)c=c(cl)c=c4)=o)=o)=o inchi inchi=1s/c28h32cl2n4o6s2/c1-17(2)13-21(31-26(36)24-14-18-5-3-4-6-23(18)41-24)27(37)33-9-11-34(12-10-33)28(38)22(16-35)32-42(39,40)25-8-7-19(29)15-20(25)30/h3-8,14-15,17,21-22,32,35h,9-13,16h2,1-2h3,(h,31,36)/t21-,22-/m0/s1key:ivyqpshhyiaufo-vxkwhmmosa-n